Adheris Health Limited · ASX:AHE
Adheris Health — Non-Deal Roadshow (February 2026)
15 slides from Adheris Health's roadshow presentation, Feb 2, 2026
Slide 1: Adheris Health Non-Deal Roadshow Presentation and Operating Cost Update
Adheris Health Limited ACN 145 327 617 Suite 287, Tenancy 111, 793 Burke Road, Camberwell, VIC 3124 investors.adherishealth.com ASX RELEASE (ASX: AHE) Adheris Health Non-Deal Roadshow Presentation and Operating Cost Update Melbourne, Australia, 02 February 2026 – Adheris Health Limited (ASX: AHE) (“
Slide 2: About Adheris Health; Forward looking statements
About Adheris Health Adheris Health (ASX: AHE) is a leader of pharmacy-driven patient engagement solutions that provide personalised patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, AI enabled platform, Adheris Health empowers the pharmacy of the
Slide 3: New Team, New Focus, Large Opportunity
New Team, New Focus, Large Opportunity 2-5 February 2026 Roadshow Presentation John Ciccio – CEO & Managing Director Sean Slattery – CFO/Executive Director 1 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 4: Leader in pharmacy-led patient engagement solutions
Leader in pharmacy-led patient engagement solutions Overview Partnering with global pharma and U.S. based pharmacies to enable a personalised medication journey to help remove barriers of care Approach Plug and play solutions that help stakeholders improve patient experiences Relationships with lead
Slide 5: Agenda
1. Operating Model & Cost Discipline 2. Commercial Realignment Agenda 3. Solidifying Our Relationships 4. Product Suite Improvements 3 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 6: Operating Model & Cost Discipline
Operating Model & Cost Discipline 4 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 7: Rebased Cost Structure & Renewed Operating Discipline
Rebased Cost Structure & Renewed Operating Discipline Substantial cost-out program and new tech platform to improve scalability and enable faster path to profitability New Tech Platform Launched (Dec 2025) • Provides more efficient omnichannel program delivery • Enables scalable growth • Additional
Slide 8: Commercial Realignment
Commercial Realignment 6 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 9: Sharpened Commercial Focus
Sharpened Commercial Focus Vaccine Administrations vs. AHE Revenue (CY) Focusing where growth is the strongest Vaccine Administrations AHE Vaccine Revenue 200 $30 Vaccine Administrations $25 AHE Revenue USD 150 • Continued decline in vaccine $20 administrations & revenue In Millions In Millions Vacc
Slide 10: Solidifying Our Relationships
Solidifying Our Relationships 8 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 11: Strengthening Our Core Relationships
Strengthening Our Core Relationships Rebuilding momentum with pharma and chain pharmacy partners ~Last 12 Months REACTIVATING PHARMA ENGAGEMENT • Re-engaging Lost Brands: productive conversations underway with previously lost brands • ~$25M of win-back opportunities in pipeline • Adding New Brands:
Slide 12: Product Suite Improvements
Product Suite Improvements 10 2-5 Feb 26 Roadshow | © 2026 Adheris Health. All rights reserved.
Slide 13: Leveling Up the Business: Digital Innovation
Leveling Up the Business: Digital Innovation Upgraded digital engagement suite will provide next-gen personalisation at scale myglp-1.com Mobile web Hi Jen, I’m here to help with your new medication. How Interactive Hello, Jen. Interactive experience are you feeling? Chat Voice GLP-1 Dietary Guidanc
Slide 14: Data-Driven Engagement: THRiV Intelligent Patient Management Platform
Data-Driven Engagement: THRiV Intelligent Patient Management Platform Engage the right patient, at the right time, with the right message Unparalleled AI-Enabled & Experience Advanced Predictive Modeling • Pioneered “direct-to- • Proprietary AI-enabled patient” engine communications • Complex algori
Slide 15: Key Short-term Priorities
Key Short-term Priorities Build Scalable Diversify Pipeline Seek Higher-margin Expand Pharmacy Enhance Digital Operation Solutions Network Engagement • Continue to optimize • Reduce dependence • Refocus our business • Increase the breadth • Level up our digital our cost base as we on vaccine revenue